{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:28:50Z","timestamp":1777710530613,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["172644KYSB20200045"],"award-info":[{"award-number":["172644KYSB20200045"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021B1515120089"],"award-info":[{"award-number":["2021B1515120089"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20200109114608075"],"award-info":[{"award-number":["JCYJ20200109114608075"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324101401004"],"award-info":[{"award-number":["JCYJ20210324101401004"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324115800003"],"award-info":[{"award-number":["JCYJ20210324115800003"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011053","name":"CAS-Croucher Funding Scheme for Joint Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170985"],"award-info":[{"award-number":["32170985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771293"],"award-info":[{"award-number":["81771293"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104167"],"award-info":[{"award-number":["82104167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejphar.2023.176275","type":"journal-article","created":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T09:59:21Z","timestamp":1702807161000},"page":"176275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Levofloxacin alleviates blood-brain barrier disruption following cerebral ischemia and reperfusion via directly inhibiting A-FABP"],"prefix":"10.1016","volume":"963","author":[{"given":"Shilun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingkang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Ni","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dewei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-2940","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby Lai Chong","family":"Hoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-9022","authenticated-orcid":false,"given":"Junlei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176275_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.176275_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac6336","article-title":"Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes","volume":"7","author":"Burak","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2023.176275_bib3","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.bmcl.2010.04.095","article-title":"Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening","volume":"20","author":"Cai","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejphar.2023.176275_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","article-title":"Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production","volume":"17","author":"Cao","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2023.176275_bib5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/01.STR.0000170644.15504.49","article-title":"The early systemic prophylaxis of infection after stroke study: a randomized clinical trial","volume":"36","author":"Chamorro","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.176275_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"Collaborators","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2023.176275_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/00004647-199811000-00012","article-title":"Estradiol protects against ischemic injury","volume":"18","author":"Dubal","year":"1998","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejphar.2023.176275_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199732020-00002","article-title":"The clinical pharmacokinetics of levofloxacin","volume":"32","author":"Fish","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2023.176275_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114604","article-title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022","volume":"240","author":"Floresta","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.176275_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejmech.2017.07.022","article-title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review","volume":"138","author":"Floresta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.176275_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5551\/jat.48710","article-title":"Fatty acid-binding protein 4 in cardiovascular and metabolic diseases","volume":"26","author":"Furuhashi","year":"2019","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.ejphar.2023.176275_bib12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2","volume":"447","author":"Furuhashi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176275_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2337\/db13-0436","article-title":"FABP4 attenuates PPAR\u03b3 and adipogenesis and is inversely correlated with PPAR\u03b3 in adipose tissues","volume":"63","author":"Garin-Shkolnik","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.176275_bib14","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00228-013-1515-7","article-title":"Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics","volume":"69","author":"Gervasoni","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176275_bib15","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jmb.2007.07.040","article-title":"Structural basis for activation of fatty acid-binding protein 4","volume":"372","author":"Gillilan","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.176275_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1107\/S2053230X14027897","article-title":"Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4)","volume":"71","author":"Gonz\u00e1lez","year":"2015","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"10.1016\/j.ejphar.2023.176275_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2012.10.022","article-title":"Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice","volume":"58","author":"Hoo","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.176275_bib18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","article-title":"Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein","volume":"274","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2023.176275_bib19","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1074\/jbc.M109.097907","article-title":"Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1","volume":"285","author":"Hui","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176275_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2023.176275_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","article-title":"Blood-brain barrier dysfunction and recovery after ischemic stroke","volume":"163\u2013164","author":"Jiang","year":"2018","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ejphar.2023.176275_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejphar.2023.176275_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003495-199856030-00013","article-title":"Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract","volume":"56","author":"Langtry","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2023.176275_bib24","article-title":"A-FABP in metabolic diseases and the therapeutic implications: an update","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.176275_bib25","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1093\/eurheartj\/ehaa207","article-title":"Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier","volume":"41","author":"Liao","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2023.176275_bib26","article-title":"BMS309403 stimulates glucose uptake in myotubes through activation of AMP-activated protein kinase","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176275_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00210-011-0667-1","article-title":"BMS309403 directly suppresses cardiac contractile function","volume":"384","author":"Look","year":"2011","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176275_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106482","article-title":"Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy","volume":"185","author":"Ma","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2023.176275_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","article-title":"Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes","volume":"1","author":"Maeda","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2023.176275_bib30","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/STROKEAHA.117.017286","article-title":"Targeting reperfusion injury in the age of mechanical thrombectomy","volume":"49","author":"Mizuma","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.176275_bib31","article-title":"Levofloxacin-associated neurotoxicity in a patient with a high concentration of levofloxacin in the blood and cerebrospinal fluid","volume":"8","author":"Nishikubo","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejphar.2023.176275_bib32","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2020.03.006","article-title":"Hyperacute management of ischemic strokes: JACC focus seminar","volume":"75","author":"Patel","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2023.176275_bib33","doi-asserted-by":"crossref","first-page":"l6983","DOI":"10.1136\/bmj.l6983","article-title":"Management of acute ischemic stroke","volume":"368","author":"Phipps","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2023.176275_bib34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41586-021-04137-3","article-title":"A hormone complex of FABP4 and nucleoside kinases regulates islet function","volume":"600","author":"Prentice","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.176275_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2023.176275_bib36","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/01.STR.30.8.1665","article-title":"17beta-estradiol reduces stroke injury in estrogen-deficient female animals","volume":"30","author":"Rusa","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.176275_bib37","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmcl.2006.12.044","article-title":"Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)","volume":"17","author":"Sulsky","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejphar.2023.176275_bib38","first-page":"163","article-title":"Assessment of gelatinases (MMP-2 and MMP-9 by gelatin zymography","volume":"57","author":"Toth","year":"2001","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.ejphar.2023.176275_bib39","series-title":"Guidance for Industry - Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","year":"2005"},{"key":"10.1016\/j.ejphar.2023.176275_bib40","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1021\/ci500503b","article-title":"Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening","volume":"54","author":"Wang","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2023.176275_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/cn5002107","article-title":"Pimozide, a novel fatty acid binding protein 4 inhibitor, promotes adipogenesis of 3T3-L1 cells by activating PPARgamma","volume":"6","author":"Wang","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2023.176275_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003721","article-title":"Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells","volume":"8","author":"Wu","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2023.176275_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome","volume":"52","author":"Xu","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2023.176275_bib44","doi-asserted-by":"crossref","first-page":"13500","DOI":"10.1039\/D2RA01057G","article-title":"Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening","volume":"12","author":"Yang","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejphar.2023.176275_bib45","doi-asserted-by":"crossref","first-page":"13500","DOI":"10.1039\/D2RA01057G","article-title":"Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening","volume":"12","author":"Yang","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejphar.2023.176275_bib46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1378\/chest.117.3.744","article-title":"Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin\/levofloxacin-containing regimens","volume":"117","author":"Yew","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2023.176275_bib47","article-title":"The isolation and characterization of murine macrophages","volume":"14","author":"Zhang","year":"2008","journal-title":"Curr Protoc Immunol Chapter"},{"key":"10.1016\/j.ejphar.2023.176275_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12974-019-1538-9","article-title":"Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway","volume":"16","author":"Zusso","year":"2019","journal-title":"J. Neuroinflammation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:25:53Z","timestamp":1762143953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923007896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":48,"alternative-id":["S0014299923007896"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176275","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levofloxacin alleviates blood-brain barrier disruption following cerebral ischemia and reperfusion via directly inhibiting A-FABP","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176275"}}